We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$726B
AUM Growth
+$72B
Cap. Flow
+$18.3B
Cap. Flow %
2.52%
Top 10 Hldgs %
22.02%
Holding
4,790
New
331
Increased
3,384
Reduced
720
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 23.98%
2 Financials 13.87%
3 Healthcare 13.39%
4 Consumer Discretionary 11.81%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VERO
3951
DELISTED
Venus Concept
VERO
$492K ﹤0.01%
960
-521
-35% -$188K
SCR
3952
DELISTED
Score Media and Gaming Inc. Class A Subordinate Voting Shares
SCR
$492K ﹤0.01%
24,700
-8,168
-25% -$154K
IPWR icon
3953
Ideal Power
IPWR
$60.8M
$491K ﹤0.01%
38,662
+10,958
+40% +$119K
AUBN icon
3954
Auburn National Bancorp
AUBN
$91.3M
$490K ﹤0.01%
13,835
-15,426
-53% -$567K
MAAC
3955
DELISTED
Montes Archimedes Acquisition Corp. Class A Common Stock
MAAC
$490K ﹤0.01%
+49,574
New +$489K
CPSS icon
3956
Consumer Portfolio Services
CPSS
$202M
$489K ﹤0.01%
108,839
RKDA icon
3957
Arcadia Biosciences
RKDA
$1.36M
$488K ﹤0.01%
4,120
+1,868
+83% +$204K
LFT
3958
Lument Finance Trust
LFT
$34.6M
$487K ﹤0.01%
115,746
+17,884
+18% +$69K
CFV
3959
DELISTED
CF Acquisition Corp. V Class A Common Stock
CFV
$487K ﹤0.01%
+49,964
New +$489K
NEWT icon
3960
NewtekOne
NEWT
$428M
$484K ﹤0.01%
13,878
-3,389
-20% -$106K
BINI
3961
DELISTED
Bollinger Innovations
BINI
0
RGLS
3962
DELISTED
Regulus Therapeutics
RGLS
$479K ﹤0.01%
58,920
+20,731
+54% +$231K
KBNT
3963
DELISTED
Kubient, Inc. Common Stock
KBNT
$479K ﹤0.01%
83,951
+37,132
+79% +$216K
ADXS
3964
DELISTED
Advaxis Inc
ADXS
$476K ﹤0.01%
1,027,417
+297,663
+41% +$150K
SIEB icon
3965
Siebert Financial
SIEB
$66.7M
$474K ﹤0.01%
98,588
-90,980
-48% -$376K
KINS icon
3966
Kingstone Companies
KINS
$289M
$473K ﹤0.01%
60,723
QRHC icon
3967
Quest Resource Holding
QRHC
$26.8M
$473K ﹤0.01%
74,505
+35,841
+93% +$166K
CLRB icon
3968
Cellectar Biosciences
CLRB
$20.5M
$472K ﹤0.01%
1,324
+509
+62% +$221K
PAYO icon
3969
Payoneer
PAYO
$2.42B
$472K ﹤0.01%
+45,539
New +$479K
POLA icon
3970
Polar Power
POLA
$5.93M
$472K ﹤0.01%
7,207
+49
+0.7% +$3.59K
FLZH
3971
Flash Sports & Media Holdings
FLZH
$63.2M
$472K ﹤0.01%
2,063
+523
+34% +$115K
ERF
3972
DELISTED
Enerplus Corporation
ERF
$472K ﹤0.01%
65,754
PLBC icon
3973
Plumas Bancorp
PLBC
$427M
$470K ﹤0.01%
14,677
-29,952
-67% -$874K
SLNO
3974
DELISTED
Soleno Therapeutics
SLNO
$469K ﹤0.01%
27,471
-27,712
-50% -$468K
RVLP
3975
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$468K ﹤0.01%
155,718
-85,013
-35% -$260K

Similar funds

Geode Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
  • Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
  • Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
  • Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
  • Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
  • Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.

Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.